logo-loader

SUDA Ltd to reveal agreement

Published: 11:00 04 Jul 2017 AEST

shutterstock_578045545_595adbf88c7d4
SUDA is focused on drug delivery

SUDA Ltd (ASX:SUD) has some material news pending in the form of a licence agreement.

The ASX has granted the company a trading halt to prepare details, with its shares placed in pre-open.

The halt will remain in place until the opening of trade on Thursday 6th July 2017, or earlier if an announcement is made to the market.

Arovella Therapeutics to enhance solid tumour pipeline with exclusive...

Arovella Therapeutics Ltd (ASX:ALA) CEO Michael Baker joins Jonathan Jackson in the Proactive studio to discuss a new, exclusive licensing agreement signed with the University of North Carolina Lineberger Comprehensive Cancer Center to incorporate a novel armouring cytokine technology (IL-12-TM)...

on 5/2/24